Jarvis Impex

Resof 400 Tablet contains Sofosbuvir, an antiviral drug used to treat chronic hepatitis C virus (HCV) infection. It works by lowering the amount of hepatitis C virus in the body and removing the virus from the blood over a period of time. Thus, it helps in reducing the amount of hepatitis C virus in the body.

Ledifos is a combination tablet that contains Ledipasvir (90 mg) and Sofosbuvir (400 mg). This medication is primarily used to treat Chronic Hepatitis C infection, caused by the hepatitis C virus (HCV). Below are the primary uses and information about Ledifos:

1. Treatment of Chronic Hepatitis C (HCV) Infection:

• Ledipasvir is an NS5A inhibitor, and Sofosbuvir is an NS5B polymerase inhibitor. Together, they block different stages of the hepatitis C virus lifecycle.
• Used for treating HCV genotypes 1, 4, 5, and 6, and it may be used in patients with or without cirrhosis (liver scarring).
• This combination is used in adult patients to help reduce the amount of HCV in the body, improve liver function, and potentially lead to a sustained virological response (SVR), meaning the virus is undetectable in the blood after treatment.

2. Alternative to Interferon-Based Therapies:

• Interferon-free regimen: Ledifos is an interferon-free treatment option, making it a preferred option for patients who cannot tolerate interferon-based treatments or those who have contraindications (e.g., autoimmune diseases or severe psychiatric disorders).

3. Management of Co-Infection with HIV:

• In some cases, Ledifos is used in patients who are co-infected with both HCV and HIV to treat the hepatitis C infection, as it is effective in people with HIV without compromising their HIV treatment regimen.

How It Works:

• Ledipasvir inhibits the NS5A protein essential for HCV replication and assembly.
• Sofosbuvir inhibits the NS5B polymerase enzyme, which is responsible for replicating the viral RNA, preventing the virus from reproducing and spreading.

Dosage and Administration:

• Typical Dosage: One tablet (containing 90 mg Ledipasvir and 400 mg Sofosbuvir) taken once daily with or without food.
• Treatment Duration: Usually taken for 12 weeks. Duration may vary based on the patient's genotype, liver condition, and treatment history.
• Follow your healthcare provider’s instructions carefully.

Common Side Effects:

• Fatigue
• Headache
• Nausea
• Diarrhea
• Insomnia
• Anemia or low hemoglobin levels (especially in co-infected HIV/HCV patients)
• Liver enzyme abnormalities (which is monitored regularly)

Sofovir 400mg Tablet is an antiviral medication. It is used along with other medications for the treatment of chronic hepatitis C virus (HCV) infection. It works by lowering a load of hepatitis C virus in the body and removing the virus from the blood over a period of time.

Hepbest Tablet is used in the treatment of HIV infection and chronic hepatitis B virus (HBV) infection. It prevents the multiplication of viruses in human cells. This stops the virus from producing new viruses and clears up your infection.

ENTAVIR 0.5MG TABLET contains Entecavir which belongs to the group of medicines called Antiviral agents. It is used to manage chronic Hepatitis-B infection in adults, children, and adolescents (2-18 years old). Hepatitis B is a viral infection that attacks the liver and can cause both acute and chronic disease

Myhep Lvir Tablet is used to treat chronic (long-term) hepatitis C virus infection in adults and children three years of age and older. Hepatitis C virus infection is a severe liver infection caused by the hepatitis C virus (HCV). It contains the active ingredients ledipasvir and sofosbuvir.

Hepcinat-Lp Tablet used to treat chronic (long-term) hepatitis C virus infection in adults and children 3 years of age and older. Hepcinat-Lp Tablet contains the active ingredients ledipasvir and sofosbuvir. Ledipasvir and Sofosbuvir work together to prevent the virus from growing and reproducing.

Hepcinat 400mg Tablet contains the active component as Sofosbuvir. It is a direct-acting antiviral medication used to treat hepatitis C virus (HCV) infection. This medication is often combined with other antiviral drugs to form a regimen that can effectively eliminate HCV from the body

Adesera 10 mg Tablet is used to treat Hepatitis B Virus infection. How does Adesera 10 mg Tablet work? Adesera 10 mg Tablet contains Adefovir Dipivoxil, which works by blocking the activity of the hepatitis B virus DNA Polymerase enzyme in the liver cells

Ledifos contains Ledipasvir as the active ingredient. It is commonly used in combination with Sofosbuvir (as in the combination form) to treat Chronic Hepatitis C Virus (HCV) infection. However, in cases where Ledipasvir is used alone, it may be for specific treatment regimens, depending on the medical guidelines and a healthcare provider’s recommendation.

Here’s more detail about the use of Ledipasvir:

1. Treatment of Chronic Hepatitis C Infection (HCV):

• Ledipasvir is a NS5A inhibitor, which blocks a protein needed for the hepatitis C virus (HCV) to replicate and assemble. This halts the viral replication process.
• It is primarily used in combination with Sofosbuvir (as in Ledifos) to treat genotypes 1, 4, 5, and 6 of HCV.
• The combination therapy (Ledipasvir and Sofosbuvir) is highly effective in reducing viral load and can potentially lead to a sustained virological response (SVR), meaning no detectable virus after the treatment course.

2. Co-Infection with HIV:

• Ledipasvir in combination with Sofosbuvir can be used in patients who are co-infected with both Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV). It effectively treats the HCV without interfering with the HIV treatment regimen.

3. Alternative to Interferon-Based Therapies:

• Ledipasvir in combination with Sofosbuvir provides an interferon-free regimen, which is well-tolerated and often preferred for patients who cannot tolerate interferon (which is common in patients with autoimmune conditions, psychiatric issues, or those who are pregnant).

How It Works:

• Ledipasvir targets the NS5A protein of HCV, which is essential for the replication and assembly of new viral particles. By blocking this protein, Ledipasvir prevents the virus from multiplying and spreading in the body.
• When used with Sofosbuvir, which inhibits the NS5B polymerase enzyme (responsible for RNA replication), this combination leads to a dual-action suppression of the virus.

Daclahep 60mg Tablet is an antiviral medication. It is used along with other medications for the treatment of chronic hepatitis C virus (HCV) infection. Daclahep 60mg Tablet should be taken in the dose and duration as advised by your doctor. It should be taken with or without food, preferably at a fixed time.

Hepcvir L 90mg/400mg Tablet helps reduce the number of hepatitis C virus by preventing it from spreading in your body. This helps control the infection and helps you recover faster. It is important that you take this medicine as prescribed, following the dosage recommended by your doctor.

Hepcvir 400 mg Tablet contains Sofosbuvir, an antiviral drug used to treat chronic hepatitis C virus (HCV) infection. It works by lowering the amount of hepatitis C virus in the body and removing the virus from the blood over a period of time. Thus, it helps in reducing the amount of hepatitis C virus in the body.

Velpanat is a combination tablet containing Sofosbuvir (400 mg) and Velpatasvir (100 mg). It is used for the treatment of Chronic Hepatitis C (HCV) infection caused by the hepatitis C virus (HCV). Velpanat is effective against multiple HCV genotypes and offers a well-tolerated, interferon-free treatment option. Below are the primary uses of Velpanat Sofosbuvir Tablets:

1. Treatment of Chronic Hepatitis C Infection (HCV):

• Sofosbuvir is a NS5B polymerase inhibitor, and Velpatasvir is an NS5A inhibitor. Together, they block two crucial steps in the replication of the hepatitis C virus.
• This combination is effective against genotypes 1, 2, 3, 4, 5, and 6 of HCV, making it suitable for a wide range of HCV patients.
• Velpanat is a direct-acting antiviral (DAA) regimen used to reduce the viral load of HCV, and in many cases, it can lead to a sustained virological response (SVR), meaning that the virus is undetectable in the blood after treatment.

2. Alternative to Interferon-Based Treatments:

• Interferon-free regimen: Unlike traditional treatments, Velpanat does not require the use of interferon, a protein that can cause severe side effects such as flu-like symptoms, fatigue, and depression.
• This makes Velpanat a preferred treatment for individuals who cannot tolerate interferon or for those with conditions that contraindicate its use.

3. Co-Infection with HIV:

• Velpanat can also be used in individuals who are co-infected with both Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV). This combination therapy effectively treats HCV without negatively impacting the HIV treatment regimen.

How It Works:

• Sofosbuvir inhibits the NS5B polymerase enzyme, which is responsible for viral RNA replication, stopping the virus from reproducing.
• Velpatasvir inhibits the NS5A protein, which is essential for the virus’s replication and assembly.
• Together, they block two key steps in the HCV lifecycle, leading to a reduction in viral load.

Revolade 50mg Tablet is used to treat low platelet count due to chronic immune (idiopathic) thrombocytopenic purpura (ITP) or chronic hepatitis C virus (HCV) infection. It is also used to treat severe aplastic anemia

Revolade is a medicine that is used for the treatment of: primary immune thrombocytopenia (ITP), a disease in which the patient's immune system destroys platelets (components in the blood that help it to clot). Patients with ITP have low platelet counts in the blood (thrombocytopenia) and are at risk of bleeding.

Revolade 25mg Tablet is used to treat low platelet count due to chronic immune (idiopathic) thrombocytopenic purpura (ITP) or chronic hepatitis C virus (HCV) infection. It is also used to treat severe aplastic anemia